The β cell population in type 1 diabetes

Novartis Foundation Symposium

Volumn 292, Issue , 2008, Pages 19-24

  Pipeleers, Daniel ^a   In 't Veld, Peter ^a   Pipeleers Marichal, Miriam ^a   Gorus, Frans ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 1;

CELL SURVIVAL; CONFERENCE PAPER; HUMAN; IMMUNOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE; METABOLISM; PANCREAS ISLET BETA CELL; PATHOLOGY;

AUTOANTIBODIES; CELL SURVIVAL; DIABETES MELLITUS, TYPE 1; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INSULIN-SECRETING CELLS; LYMPHOCYTES;

EID: 56249084560     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (21)

1. Foulis AK 1987 The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus. J Pathol 152:141-148
2. Foulis AK, Farquharson MA, Meager A 1987 Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus. Lancet 2:1423-1427
3. Gepts W 1965 Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633
4. Gepts W 1981 Islet changes in human diabetes. In: Cooperstein SJ, Watkins D (eds) Biochemistry, physiology and pathology of the islets of Langerhans. Academic press, New York, p 321-356
5. Gorus FK, Pipeleers DG, Belgian Diabetes Registry 2001 Prospects for predicting and stopping the development of type 1 diabetes. Best Pract Res Clin Endocrinol Metab 15:371-389
6. Harrison LC, Campbell IL, Allison J, Miller JE 1989 MHC molecules and beta cell destruction. Immune and nonimmune mechanisms. Diabetes 38:815-818
7. Huang X, Yuang J, Goddard A et al 1995 Interferon expression in the pancreas of patients with type 1 diabetes. Diabetes 44:658-664
8. In't Veld P, Lievens D, De Grijse J et al 2007 Screening for insulitis in adult autoantibody-positive organ donors. Diabetes 56:2400-2404
9. Itoh N, Hanafusa T, Miyazaki A et al 1993 Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 92:2313-2322
10. Keymeulen B, Vandemeulebroucke E, Ziegler AG et al 2005 Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. N Engl J Med 23:2598-2608
11. Liu E, Eisenbarth GS 2002 Type 1A diabetes mellitus-associated autoimmunity. Endocrinol Metab Clin North Am 31:391-410
12. Madsbad S 1983 Prevalence of residual B cell function and its metabolic conseqences in type 1 (insulin-dependent) diabetes. Diabetologia 24:141-147
13. Marker J, Maclaren N 2001 Immunopathology of immune-mediated (type 1) diabetes. Clin Lab Med 21:15-30
14. Meier JJ, Bhushan A, Butler AE, Rizza RA, Butler PC 2005 Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration? Diabetologia 48:2221-2228
15. Pavlovic D, Van De Winkel M, Van der Auwera B et al 1997 Effects of interferon-γ and glucose on major histocompatibility complex class I and class II expression by pancreatic β- and non-β-cells. J Clin Endocrinol Metab 82:2329-2336
16. Pipeleers D, Ling Z 1992 Pancreatic beta cells in insulin-dependent diabetes. Diabetes Metab Rev 8:209-227
17. Stansfield OH, Warren S 1928 Inflammation involving the islands of Langerhans in diabetes; report on pathologic findings. New Engl J Med 198:686-687
18. Vandewalle CL, Coeckelberghs M, De Leeuw IH et al 1997 Epidemiology, clinical aspects and biology of IDDM patients under age 40 years. The Belgian Diabetes Registry. Diabetes Care 20:1556-1562
19. Wallensteen M, Dahlquist G, Persson B et al 1988 Factors influencing the magnitude, duration, and rate of fall of B-cell function in type 1 (insulin-dependent) diabetic children followed for two years from their clinical diagnosis. Diabetologia 31:664-669
20. Weets I, Van Autreve J, Van der Auwera BJ et al 2001 Male-to-female excess in diabetes diagnosed in early adulthood is not specific for the immune-mediated form nor is it HLA-DQ restricted: possible correlation to increased body mass index. The Belgian Diabetes Registry. Diabetologia 44:40-47
21. Yang Y, Santamaria P 2006 Lessons on autoimmune diabetes from animal models. Clin Sci (Lond) 110:627-639